Development of a Patient-reported Outcome Measure for Women With Chronic Pelvic Pain
Enrolling by invitationNCT06083597
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to develop a patient questionnaire that can be utilized to assess the benefit of treatments of chronic pelvic pain in research studies. The information collected from a series of patient interviews will lead to the development of a questionnaire that accounts for the full impact of chronic pelvic pain from an affected woman's perspective.
Study details
- Official title
- Development of a Patient-reported Outcome (PRO) Measure for Women With Chronic Pelvic Pain (CPP)
- Conditions
- Chronic Pelvic Pain Syndrome
- Pelvic Congestive Syndrome
- Interventions
- Other: Qualitative interview
- Sponsor
- Weill Medical College of Cornell University
- Collaborators
- Society of Interventional Radiology Foundation; Evidera
- Start date
- 2023-07-01
- Primary completion
- 2026-12-31
- Sex
- Female
- Age range
- from 18 Years to 60 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
I. First phase of study evaluation women with presumed venous origin chronic pelvic pain Inclusion Criteria : 1. Non-menopausal women ≥18 years old. a. Women who are not menstruating because of ovarian suppression therapy for CPP are eligible. 2. CPP meeting the American College of Obstetricians and Gynecologists criteria. 3. Patient pain is primarily of pelvic and/or pelvic floor origin. Patient may experience other pain symptoms, including bowel, bladder, musculoskeletal, skin allodynia and hyperalgesia, or lower extremity venous or vulvar pain. 4. Imaging demonstrating multiple tortuous pelvic varicose veins \> 5 mm in diameter in the ovarian, utero vaginal, and/or uterine arcuate venous plexus. a. Imaging must be documented from trans vaginal ultrasound, trans abdominal ultrasound, magnetic resonance imaging, computed tomography, catheter venogram, or trans fundal pelvic venogram. If laparoscopic images are available to confirm veins this size, this would be acceptable as well. 5. Venous contribution to CPP, as determined by clinical impression from a CPP specialist. Clinical impression will be based on the presence of the following symptoms and physical findings: a. Symptoms: i. CPP increased with standing, walking, or lifting ii. CPP increased at the end of the day iii. CPP improved by laying down iv. Sexually provoked prolonged post-coital ache b. Physical findings: i. Adnexal tenderness on gentle bimanual exam ii. Tenderness at the ovarian point trans-abdominally iii. Tenderness of the uterus 6. Participant can read, communicate clearly, and understand English or Spanish. 7. Participant is willing and able to participate in an interview and complete questionnaires. 8. Participant is willing and able to provide informed consent. Exclusion Criteria: 1. Pain symptoms should primarily be of pelvic and/or pelvic floor origin (inclusion criteria #3 above). Pain should not be exclusively low back, hips, symphysis, allodynia or hyperalgesia of the skin, or from varicose veins of the vulvar and/or lower extremities. 2. Pain thought primarily to be due to endometriosis, pelvic floor myalgia, a musculoskeletal etiology, irritable bowel disease, or painful bladder syndrome/interstitial cystitis. 3. Obvious endometriosis based on physical exam or laparoscopy findings. 4. Patients previously treated with a technically successful surgery or vascular procedure for a venous disorder of the pelvis or renal vein. 5. Participant has any clinically relevant medical con…
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06083597